Samsrita labs Limited has submitted its mandatory compliance certificate under SEBI regulations for the quarter ended 31.03.2026. The pharmaceutical company filed the certificate with stock exchanges on 07-04-2026, fulfilling its regulatory obligations under the Securities and Exchange Board of India framework.

Regulatory Compliance Filing

The compliance certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The document was prepared by the company's Registrar and Transfer Agent, Venture Capital and Corporate Investments Private Limited, and submitted to both BSE Limited and Metropolitan Stock Exchange of India Limited.

Certificate Confirmation

The compliance certificate confirms that Samsrita Labs Limited has adhered to all required procedures for securities dematerialization during the quarter. According to the certificate issued by Venture Capital and Corporate Investments Private Limited, all securities received for dematerialization have been properly mutilated and cancelled after due verification.

The certificate specifically states that the names of both depositories - National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) - have been updated in the company's records as registered owners within the mandated 15-day timeframe upon receipt of valid Dematerialization Request Forms and share certificates.

Corporate Information

The filing was signed by K. Krishnam Raju, Chairman and Wholetime Director (DIN: 00874650), on behalf of Samsrita Labs Limited. The company maintains its registered and corporate office at 6-3-354/13/B2, Suryateja Apartments, Hindinagar, Punjagutta, Hyderabad 500082.

This quarterly compliance certificate represents part of the company's ongoing regulatory obligations to maintain transparency and proper record-keeping in securities transactions and depository services.

Samsrita labs has announced its strategic expansion into the Pet Animal Healthcare and Wellness segment, marking a significant diversification move for the healthcare company. The expansion falls within the scope of the existing Object Clause of the company's Memorandum of Association and was disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Strategic Expansion Details

The company's expansion into pet healthcare represents a natural extension of its existing human healthcare expertise. SAMSrita LABS LIMITED aims to leverage its rigorous healthcare standards to provide high-quality, professional grooming and therapeutic services in the pet wellness space.

Market Rationale and Growth Drivers

The expansion is supported by compelling market fundamentals in India's pet care ecosystem. The company has identified several key factors driving this strategic decision:

• Market Growth: The Indian pet care market is experiencing robust CAGR of over 20%
• Economic Drivers: Rising disposable incomes and urban demographics fuel market expansion
• Consumer Behavior Shift: The "Pet Humanization" trend transforms pet services from discretionary luxury to essential wellness category
• Strategic Synergy: Application of healthcare expertise to pet wellness creates competitive advantage

Market Positioning and Value Creation

SAMSrita LABS LIMITED believes this strategic expansion will create long-term value for shareholders by accessing a high-growth, high-margin consumer segment. The pet humanization trend has fundamentally changed how pet owners view grooming and spa services, elevating these offerings from optional luxuries to essential wellness requirements.

The company's approach involves applying its established healthcare standards to the pet wellness market, potentially creating a differentiated service offering in the rapidly evolving pet care landscape.

Corporate Disclosure

The announcement was made through a formal disclosure dated 11-03-2026, signed by K. Krishnam Raju, Chairman & Whole-time Director. The disclosure ensures compliance with regulatory requirements while informing stakeholders of the company's strategic direction and growth initiatives.